Joakim Wijkstrom, SVP, Chief Marketing Officer at Vanda Pharmaceuticals Inc. (VNDA), sold 61,600 shares at $8.27 ($509K) on 2026-03-02, disclosed to the SEC on 2026-03-04.
Seasonal sale ($509k) by SVP, Chief Marketing Officer — this insider has traded VNDA in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.27 | 30,800 | $255K | 50.0% |
| 2 | $8.27 | 30,800 | $255K | 50.0% |
| Total | $8.27 avg | 61,600 | $509K | 100% |
| Filing → |
| VNDA | SELL | 2023-03-06 | $74K | — | Filing → |
| VNDA | SELL | 2022-08-23 | $37K | — | Filing → |
| VNDA | SELL | 2022-03-02 | $156K | — | Filing → |